NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$7.61
−0.26%Sep 16, 2026, 13:00 UTC
NeurAxis announced that a major national health insurer issued a new medical policy covering its PENFS neuromodulation therapy, expanding access to over 18 million additional covered lives.
Source:Aug 19, 2026, 00:00 UTC
Neuraxis, Inc. granted restricted stock units to executives Brian Carrico, Adrian Miranda, and Thomas Carrico on July 24, 2026, as part of their compensation packages.
Aug 11, 2026, 18:47 UTC
NeurAxis, Inc. held its Q2 2026 earnings call on August 11, 2026.
Source: